Dysphagia is closely related to frailty in mild-to-moderate Alzheimer’s disease

被引:0
|
作者
Merve Güner
Arzu Okyar Baş
Serdar Ceylan
Zeynep Kahyaoğlu
Süheyla Çöteli
Pelin Ünsal
Çağatay Çavuşoğlu
Cemile Özsürekci
Burcu Balam Doğu
Mustafa Cankurtaran
Meltem Gülhan Halil
机构
[1] Hacettepe University,Faculty of Medicine, Department of Internal Medicine, Division of Geriatrics
来源
关键词
Dysphagia; Frailty; Dementia; Quality of life;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Increased urinary level of oxidized nucleosides in patients with mild-to-moderate Alzheimer's disease
    Lee, Sang Hee
    Kim, Inseong
    Chung, Bong Chul
    [J]. CLINICAL BIOCHEMISTRY, 2007, 40 (13-14) : 936 - 938
  • [42] Galantamine reduces behavioral and psychotic disturbances and behavior-related caregiver burden in mild-to-moderate Alzheimer's disease
    Monsch, AU
    Krebs-Roubicek, E
    Braendle, D
    Hock, C
    [J]. NEUROBIOLOGY OF AGING, 2002, 23 (01) : S120 - S120
  • [44] Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer’s disease
    Anne Rijpma
    Olga Meulenbroek
    Anneke M. J. van Hees
    John W. C. Sijben
    Bruno Vellas
    Raj C. Shah
    David A. Bennett
    Philip Scheltens
    Marcel G. M. Olde Rikkert
    [J]. Alzheimer's Research & Therapy, 7
  • [45] Neuropsychophysiological Evaluation of Three Doses of S 12024-2 in Mild-to-Moderate Alzheimer’s Disease
    C. Derouesné
    B. Renault
    B. Gueguen
    M. Van der Linden
    L. Lacomblez
    P. Homeyer
    L. Ouss
    E. Neuman
    M. Malbezin
    S. Barrandon
    D. Guez
    [J]. Clinical Drug Investigation, 1997, 14 : 301 - 306
  • [46] Mild-to-moderate active luminal Crohn's disease
    Michetti, Pierre
    Juillerat, Pascal
    Mottet, Christian
    Pittet, Valerie
    Gonvers, Jean-Jacques
    Vader, John-Paul
    Froehlich, Florian
    Felley, Christian
    [J]. DIGESTION, 2007, 76 (02) : 92 - 98
  • [47] Changes in Speech Chunking in Reading Aloud is a Marker of Mild Cognitive Impairment and Mild-to-Moderate Alzheimer's Disease
    De Looze, Celine
    Kelly, Finnian
    Crosby, Lisa
    Vourdanou, Aisling
    Coen, Robert F.
    Walsh, Cathal
    Lawlor, Brian A.
    Reilly, Richard B.
    [J]. CURRENT ALZHEIMER RESEARCH, 2018, 15 (09) : 828 - 847
  • [48] Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease
    Rijpma, Anne
    Meulenbroek, Olga
    van Hees, Anneke M. J.
    Sijben, John W. C.
    Vellas, Bruno
    Shah, Raj C.
    Bennett, David A.
    Scheltens, Philip
    Rikkert, Marcel G. M. Olde
    [J]. ALZHEIMERS RESEARCH & THERAPY, 2015, 7
  • [49] Neuropsychophysiological evaluation of three doses of S 12024-2 in mild-to-moderate Alzheimer's disease
    Derouesne, C
    Renault, B
    VanderLinden, M
    Lacomblez, L
    Homeyer, P
    Ouss, L
    Neuman, E
    Malbezin, M
    Barrandon, S
    Guez, D
    [J]. CLINICAL DRUG INVESTIGATION, 1997, 14 (04) : 301 - 306
  • [50] Retrospective cohort study of the efficacy of caprylic triglyceride in patients with mild-to-moderate Alzheimer's disease
    Maynard, Steven Douglas
    Gelblum, Jeff
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2013, 9 : 1619 - 1627